Acil Serviste Covid-19 ve Yönetimi

Yıl 2020, COVID-19 Özel Sayı, 116 - 122, 30.04.2020

Yusuf Yurumez , Mehmet Alaçam

https://doi.org/10.34084/bshr.721971

Cited By: 3

Öz

Covid-19’un en önemli özelliklerinden birisi insandan insana bulaşabilmesi ve bulaşın enfekte kişi ile yakın mesafede bulunma sırasında ortama saçılan damlacıklar yoluyla gerçekleşebilmesidir. Bu nedenle acil servisler en riskli alanlar içerisinde yer almaktadır. Covid-19 hastaları acil servise ayaktan veya ambulans ile başvurabilir. Ayaktan başvurular için acil servisin girişinde ya da dış kısmında bir triaj alanı ve acil servisin diğer alanlarından farklı bir yerde muayene alanı düzenlenmelidir. Resüsitasyon gerektiren ambulansla getirilen hastalar resüsitasyon alanına alınmalı, resüsitasyon gerektirmeyen hastalar muayene odasına alınmalı ve değerlendirilmelidir. Bu hastaların taburculuk veya yatış kararları klinik durumları dikkate alınarak verilmeli, yoğun bakım gerektiren hastalar bekletilmeksizin hızla yatırılmalıdır.

Abstract

One of the most important features of Covid-19 is that it can be transmitted from person to person, and the contamination can be achieved by the airbone droplets in close range infected person. For this reason, emergency services are the most risky areas. Covid-19 patients can apply to emergency service by using an ambulance or outpatient. For outpatient applications, a triage area must be organized at the enterance or outside the emergency service and the examination room should be located in the different area then the other departments of emercengy service. Patients brought by ambulance requiring resuscitation should be taken to the resuscitation area, patients not requiring resuscitation should be taken to the examination room and evaluated. The discharge or hospitalization decisions of these patients should be considered by their clinical situations and the patients that needs intensive care must be hospitalizated quickly without waiting.

Keywords: Covid-19, emergency room, infection.

Anahtar Kelimeler

Covid-19, acil servis, enfeksiyon

Covid-19 and Management in Emergency Service

Öz

One of the most important features of Covid 19 is that it can be transmitted from person to person, and the contamination can be achieved by the airbone droplets in close range infected person. For this reason, emergency services are the most risky areas. Covid 19 patients can apply to emergency service by using an ambulance or outpatient. For outpatient applications, a triage area must be organized at the enterance or outside the emergency service and the examination room should be located in the different area then the other departments of emercengy service. Patients brought by ambulance requiring resuscitation should be taken to the resuscitation area, patients not requiring resuscitation should be taken to the examination room and evaluated. The discharge or hospitalization decisions of these patients should be considered by their clinical situations and the patients that needs intensive care must be hospitalizated quickly without waiting.

Anahtar Kelimeler

Covid-19, emergency service, infection

Kaynakça

• 1. CDC. HAN Archive-00426|Health Alert Network (HAN). https://emergency.cdc.gov/han/han00426.asp PublishedFebruary 11, 2020. Accessed March 19, 2020.
• 2. World Health Organization. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/ who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Published February 11, 2020. Accessed March 08, 2020.
• 3. CDC. 2019 novel Coronavirus (2019-nCoV) frequently asked questions and answers. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/ 2019-ncov/faq.html. Published February 11, 2020. Accessed March 18, 2020
• 4. CDC. 2019 Novel Coronavirus (2019-nCoV) transmission. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/about/ transmission.html Published February 11, 2020. Accessed March 12, 2020
• 5. World Health Organization. Corona virüs disease 2019 (COVID-19) situation report – 81 https://www.who.int/docs/default-source/coronaviruse/situation-reports/ 20200320-sitrep-81-covid-19.pdf?sfvrsn=8894045a_2. Published April 10, 2020. Accessed April 10, 2020.
• 6. World Health Organization. Corona virüs diseases out break situation. https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Published April 11,2020. Accessed 11 April,2020. 7. Türkiye Cumhuriyeti Sağlık Bakanlığı. Türkiye’deki güncel durum. https://covid19.saglik.gov.tr/ (Yayın tarihi: 10.04.2020)
• 8. Giwa A. Et al. Novel Coronavirus 2019 SARS-CoV2 (COVID 19): An update over view for emergency clinicians-03-23-20.EB MEDICINE. March 23,2020.
• 9. CDC. 2019 Novel Coronavirus (2019-nCoV) symptoms. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/about/symptoms. html. Published February 11, 2020. Accessed March 19, 2020
• 10. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506.
• 11. CDC. 2019 Novel Coronavirus (2019-nCoV) clinical care. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinicalguidance-management-patients.html. Published February 11, 2020. Accessed March 19, 2020.
• 12. CDC. 2019 Novel Coronavirus (2019-nCoV) pregnant women. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/specificgroups/pregnancy-faq.html. Published February 11, 2020. Accessed March 19, 2020
• 13. CDC. 2019 Novel Coronavirus (2019-nCoV) Testing. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/about/testing.html. Published February 11, 2020. Accessed March 19, 2020
• 14. Chavez S, Long B, Koyfman A, Liang SY. Coronavirus Diseases (COVID19): A Primer for emergency physicians. YAJEM.158841. February 18,2020.
• 15. Luis GC, Roberta P et al. EUSEM Position paper on Emergency Medical Systems response to Covid-19. Received 9 March 2020 Accepted 12 March 2020 doi: 10.1097/MEJ.0000000000000701.
• 16. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. Covid-19 (SARS-CoV-2) Rehberi. 2 Nisan 2020. https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf
• 17. World Health Organisation. WHO. Rational use of personal protective equipment for corona virüs disease (COVID-19) and considerations during severe short ages. April 2020.
• 18. Jın et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus infected pneumonia. Military Medica lResearch (2020) 7;4.
• 19. Alhazzani W, Møller MH, Arabi YM, et al. Surviving sepsis campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19), 101; 2020
• 20. Phua J.,Weng L. Et al. Intensive care management of corona virüs disease 2019: challenges and recommendations. www.thelancet.com/respiratory Published online April 6, 2020. https://doi.org/10.1016/S2213-2600(20)30161-2
• 21. Wax RS, Christian MD. Practical recommendations for critical care and anesthesiology team scaring for novel coronavirus (2019-nCoV) patients. Can J Anaesth 2020; published online Feb 12. DOI:10.1007/s12630-020-01591-x.
• 22. WHO-China Joint Mission. Report of the WHO-China Joint Mission on Corona virüs Disease 2019 (COVID-19). Feb 28, 2020. https://www.who.int/docs/default-source/coronaviruse/who-chinajoint-mission-on-covid-19-final-report.pdf (Accessed March 7, 2020).
• 23. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020.